Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Shaanxi Panlong Pharmaceutical presents compounds for leukemia

Dec. 24, 2020

Beijing Tide Pharmaceutical synthesizes new ATR kinase inhibitors

Dec. 24, 2020

University of Minnesota discloses BET inhibitors

Dec. 24, 2020

IFM Due discloses hSTING receptor antagonists

Dec. 23, 2020

Emory University patents legumain inhibitors

Dec. 23, 2020

Phase III DOM-INNATE trial of SGX-942 does not show statistically significant benefit

Dec. 23, 2020

DTRM-555 meets primary endpoint in first-in-human study with patients with B-cell lymphomas

Dec. 22, 2020

Menin/KMT2A inhibitor KO-539 shows encouraging preliminary results for treating R/R AML

Dec. 22, 2020

Celgene synthesizes new CKI-alpha degradation inducers

Dec. 22, 2020

FDA approves Xpovio for multiple myeloma after at least one prior therapy

Dec. 21, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...